APA (7th ed.) Citation

Dooling, K., Gargano, J. W., Moulia, D., Wallace, M., Rosenblum, H. G., Blain, A. E., . . . Oliver, S. E. (2021). Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2021. MMWR: Morbidity & Mortality Weekly Report, 70(38), 1344. https://doi.org/10.15585/mmwr.mm7038e2

Chicago Style (17th ed.) Citation

Dooling, Kathleen, et al. "Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2021." MMWR: Morbidity & Mortality Weekly Report 70, no. 38 (2021): 1344. https://doi.org/10.15585/mmwr.mm7038e2.

MLA (9th ed.) Citation

Dooling, Kathleen, et al. "Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2021." MMWR: Morbidity & Mortality Weekly Report, vol. 70, no. 38, 2021, p. 1344, https://doi.org/10.15585/mmwr.mm7038e2.